Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 11—November 2018
Policy Review

Stakeholder Insights from Zika Virus Infections in Houston, Texas, USA, 2016–2017

Stephanie R. MorainComments to Author , Catherine S. Eppes, Joslyn W. Fisher, Courtenay R. Bruce1, Martha Rac, Kjersti M. Aagaard, Rebecca Lunstroth, Savitri Fedson, Pallavi Dinesh, and Jean L. Raphael
Author affiliations: Baylor College of Medicine, Houston, Texas, USA (S.R. Morain, C.S. Eppes, J.W. Fisher, C.R. Bruce, M. Rac, K.M. Aagaard, S. Fedson, P. Dinesh, J.L. Raphael); McGovern Medical School at the University of Texas Health Science Center, Houston (R. Lunstroth)

Main Article

Table 1

Roles of key stakeholders interviewed with regard to Zika virus infections in Houston, Texas, USA, 2016–2017

Primary role No. respondents
Pediatrics/neonatology 9
Obstetrics–gynecology or maternal–fetal medicine 8
Public health 8
Pathology 6
Infectious disease 3
Operations/leadership 2
Nursing 1
Genetic counseling
Total 38

Main Article

1Current affiliation: Houston Methodist Hospital, Houston, Texas, USA.

Page created: October 16, 2018
Page updated: October 16, 2018
Page reviewed: October 16, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.